Precision BioSearch supports Pioneer Group’s ‘Launch Accelerator’ programme
Precision BioSearch Co-founder, Malcolm Silander, will deliver a half-day seminar to 14 Founders of the UK’s most exciting early-stage biotech companies as part of the Pioneer Group Launch Accelerator programme.
Jon Moore – Founding CEO
Pheno Therapeutics engaged Precision Biosearch to identify a new full-time CEO. We were very happy with the service we received. The Precision Biosearch team were able to provide a shortlist of candidates promptly and their notes on the candidates proved their ability to assess personality and fit to a start up culture in addition to […]
Myricx Bio partners with Precision BioSearch to appoint CSO
Precision BioSearch was delighted to partner with Myricx Bio, a biotech company focusing on the discovery and development of a completely novel class of selectively cytotoxic payloads for antibody-drug conjugates (ADCs), to secure the appointment of Dr Francesca Zammarchi as Chief Scientific Officer.
‘How to be an early-stage Biotech CEO in challenging times’, cited by Citeline – Duplicate – [#1444]
Our Co-founder, Malcolm Silander, chaired the discussion which formed the basis of Andrew McConaghie’s (In Vivo / Citeline) recent article, ‘How to be an early-stage Biotech CEO in challenging times’.
Precision BioSearch expands C-suite team of SENISCA with COO and CDO appointments – Duplicate – [#1430]
Precision BioSearch partnered with SENISCA, an award-winning biotechnology company developing RNA based therapeutics to reverse cellular senescence and target age-related disease
Hiring with precision: candidate behaviours in a post-boom market – Duplicate – [#2634]
Biotech investment has taken a considerable downward turn over the past 18 months, impacted by the global macroeconomic situation and a return to lower levels of funding post-pandemic.
Hiring with precision: candidate behaviours in a post-boom market
Biotech investment has taken a considerable downward turn over the past 18 months, impacted by the global macroeconomic situation and a return to lower levels of funding post-pandemic.
Precision BioSearch expands C-suite team of SENISCA with COO and CDO appointments
Precision BioSearch partnered with SENISCA, an award-winning biotechnology company developing RNA based therapeutics to reverse cellular senescence and target age-related disease
‘How to be an early-stage Biotech CEO in challenging times’, cited by Citeline
Our Co-founder, Malcolm Silander, chaired the discussion which formed the basis of Andrew McConaghie’s (In Vivo / Citeline) recent article, ‘How to be an early-stage Biotech CEO in challenging times’.
Precision BioSearch, corporate sponsorship of Bio Equity Europe 2023
Precision BioSearch is delighted to announce our corporate sponsorship of Bio Equity Europe 2023, being held from May 14-16th in Dublin, Ireland.